Man City's Aguero has COVID-19, in race for Liverpool clash

Manchester City forward Sergio Aguero has tested positive for coronavirus and faces a race to be fit for the clash with Liverpool on Feb. 7.

Aguero had been in isolation after coming into close contact with someone who had tested positive for COVID-19 and missed City's last three matches against Brighton & Hove Albion, Crystal Palace and Aston Villa.

- Stream LIVE games and replays on ESPN+ (U.S. only)
- Dawson: Resilient City show championship mettle to go top

But, despite his self-isolation, Aguero tweeted on Thursday that results of a recent test have shown he is positive for the virus.

"After a close contact, I've been self-isolating and the latest test I took was positive for COVID-19," he posted on Twitter.

"I had some symptoms and I'm following doctor's orders for recovery. Take care, everyone!"

Aguero will now need to self-isolate for 10 days for his positive test but needs a negative result before he can play for the club again.

The news is a blow to both City, who are sweating on the fitness of midfielder Kevin De Bruyne and Kyle Walker, and Aguero as the injuries have restricted the Argentina forward to just five Premier League appearances this season.

City have seen an increase in coronavirus positives within the club since Christmas, with five players self-isolating in early January.

The club launched an investigation into a New Year's Eve party hosted by defender Benjamin Mendy, while matches against Everton and Aston Villa were postponed.

City face Cheltenham Town in the FA Cup fourth round on Saturday, with clashes against West Bromwich Albion, Sheffield United and Burnley following before a meeting with Liverpool at Anfield.

Liverpool and City have been the top two sides in the Premier League each of the last two seasons -- with Pep Guardiola's side missing out on the title last term.

City have won their last six league matches and sit second in the table. They are two points behind leaders Manchester United with a game in hand.